Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05505422
Other study ID # 2023-10663
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date September 15, 2022
Est. completion date March 15, 2024

Study information

Verified date April 2023
Source Centre hospitalier de l'Université de Montréal (CHUM)
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Intraoperative hemodynamic management is vital in the success of lung transplantation. Significant intraoperative hemodynamic compromise and hypoxic episodes may contribute to an increase in severe postoperative complications related to hypoperfusion, including cerebrovascular accidents, acute kidney injury, and mesenteric ischemia. In certain lung transplant recipients, intraoperative cardiopulmonary support is mandatory because certain factors would make "off-pump" transplants unsafe. These include severe pulmonary hypertension or severe ventricular dysfunction. In such patients, routine intraoperative support should be employed. However, it is possible to conduct the lung transplant without cardiopulmonary support in the remainder of patients who do not have severe pulmonary hypertension or right heart dysfunction. In such patients, the lung transplant may be started without cardiopulmonary support. However, cardiopulmonary support may be initiated "on-demand" if there is development or impending hemodynamic embarrassment or hypoxia. Conversely, the opposite approach would be to routinely conduct all lung transplant operations using cardiopulmonary support, which may also lead to specific ECMO-related complications. The investigators question whether on demand intraoperative ECMO in patients with significant risk factors will produce severe postoperative complications in a rate similar to routine ECMO.


Description:

Hypothesis: In patients where cardiopulmonary bypass (CPB) / ECMO is not mandatory, on-demand use of intra-operative ECMO is equivalent to routine use for patients undergoing lung transplant. The study will be a prospective, randomized controlled trial. The investigators seek to compare outcomes of two different strategies of cardiopulmonary support during lung transplantation; routine support with ECMO versus selective (on-demand), indication- based support with ECMO. The allocation ratio will be 1:1. A multi-center trial is necessary to allow for a sufficient sample size. However, the investigators believe a pilot study is essential to determine feasibility before embarking on such a significant undertaking. In this preliminary pilot study, recruitment will be limited to lung transplant patients at the Centre hospitalier de l'Universite de Montreal (CHUM). The primary purpose of the pilot study will be to define recruitment ability and assess the feasibility of conducting the study. Depending on the results of this pilot study, the next step would be to expand the study to multiple lung transplant centers to achieve an adequate sample size and power, allowing the investigators to answer the question of interest.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 29
Est. completion date March 15, 2024
Est. primary completion date March 15, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: Patients undergoing lung transplant surgery during the study period (6 months) Exclusion Criteria: 1. Inability to provide consent for the study or patient refusal 2. Retransplantation 3. Multi-organ transplantation 4. Lung transplant recipients where intraoperative support is mandatory and "off- pump" transplant would be unsafe: a. Severe pulmonary hypertension (PH): i. Systolic pulmonary artery pressure (PAP) = 80 mm Hg on echocardiography, right heart catheterization, or pulmonary artery catheter measurement ii. Mean PAP = 55 mm Hg on echocardiography, right heart catheterization, or pulmonary artery catheter measurement iii. The ratio of mean pulmonary to systemic artery pressure of more than 0.66 b. Moderate to severe right ventricular (RV) hypokinesis or dysfunction c. Left ventricular dysfunction: Defined as ejection fraction (LVEF) < 50% on echocardiography, ventriculography, computed tomography (CT), or magnetic resonance imaging (MRI) d. Significant coronary artery disease (CAD)requiring stenting or surgical grafting

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Routine ECMO
Routine ECMO during lung tansplant
On demand ECMO
Selective, indication-based intraoperative cardiopulmonary support. In this group, the transplant will be planned without cardiopulmonary support. intraoperative ECMO will be used selectively based on hemodynamic and/or gas exchange abnormalities : Inability to maintain adequate hemodynamics and stable perfusion or oxygenation during surgery Prolonged high dose pressor required to maintain adequate perfusion A sustained drop in cerebral saturation > 25% of baseline despite initial attempts at optimization Inability to tolerate pulmonary artery clamping Inadequate gas exchange despite attempts at the optimization of ventilator parameters and treatments related to respiratory mechanics and ventilation/perfusion matching Inadequate exposure to the surgical field

Locations

Country Name City State
Canada Centre Hospitalier de l'Université de Montréal Montreal Quebec

Sponsors (1)

Lead Sponsor Collaborator
Centre hospitalier de l'Université de Montréal (CHUM)

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Other Incidence and grade of primary graft dysfunction (PGD) at 0, 24, 48, and 72 hours From the end of surgery up to 72 hours after surgery
Other Incidence of postoperative bleeding complications. The definition of bleeding complication is based on Bleeding Academic Research Consortium (BARC) classification 14 days after surgery
Other Intraoperative blood product transfusion requirements From the beginning of surgery to transfer to the intensive care unit
Other Perioperative blood product transfusion requirements From the beginning of surgery to 14 days after surgery, including return to the operating room for subsequent surgeries 14 days
Other Intensive care unit and hospital length of stay in days Beginning from the arrival to the intensive care unit immediately after surgery
Other Duration of mechanical ventilation in hours BiPAP and CPAP are not considered mechanical ventilation. Tracheostomy is not considered mechanical ventilation if a ventilator is not needed. Beginning from the arrival to the intensive care unit immediately after surgery, up to about 30 days
Other Incidence of re-intubation 14 days
Other Incidence of postoperative tracheostomy 21 days
Other Incidence of acute kidney injury (AKI) within 14 days. The definition of AKI is based on Kidney Disease; improving global outcomes (KDIGO) classification 14 days
Other Incidence of vascular complications 14 days
Other Forced expiratory volume at 1 second (FEV1) at 1 year 1 year
Other Incidence of stroke 1 year
Other Incidence of acute rejection episodes 1 year
Primary Study recruitment rate 6 months after the onset of study
Secondary Percentage of patients loss to follow-up 1 year
Secondary The composite incidence of death, disabling stroke, grade 2 or 3 primary graft dysfunction at 72 hours, major bleeding (BARC grade 3a, 3b or 5), vascular complications, or stage II or III acute kidney injury at 14 days. 14 days
Secondary Incidence of all-cause mortality at 30 days, 90 days, and one year 1 year
Secondary Incidence of postoperative stroke / cerebrovascular accident 14 days
Secondary Incidence of an Early major postoperative neurologic complication (EMPNC): This includes stroke, severe encephalopathy, and severe seizures diagnosed within 14 days after surgery. 14 days
Secondary Incidence of severe postoperative complications. This is defined as Clavien-Dindo grade III complication or greater 14 days
See also
  Status Clinical Trial Phase
Recruiting NCT03181620 - Sedation Administration Timing: Intermittent Dosing Reduces Time to Extubation N/A
Recruiting NCT04205058 - Coffee After Pancreatic Surgery N/A
Completed NCT06425601 - A Comparison of Silicone Versus Polyvinylchloride (PVC) Drains Following VATS Lobectomy N/A
Completed NCT02565420 - Saline Versus Lactated Ringer's Solution: The SOLAR Fluid Trial N/A
Recruiting NCT04519593 - ABSOLUTELY: A Temporary Uterine Blood Supply Occlusion for Laparoscopic Myomectomy in Patients With UTErine LeiomYoma N/A
Completed NCT03662672 - Rib Raising for Post-operative Ileus N/A
Completed NCT03787849 - Epigenetics in PostOperative Pediatric Emergence Delirium N/A
Active, not recruiting NCT05886387 - a Bayesian Analysis of Three Randomised Clinical Trials of Intraoperative Ventilation
Not yet recruiting NCT06351475 - Efficacy of Intraoperative Use of 20% Albumin Combined With Ringer Lactate Versus Ringer Lactate During Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy N/A
Not yet recruiting NCT05052021 - The South African Coronavirus Disease of 2019 (COVID-19) Surgical Outcomes Study
Not yet recruiting NCT03639012 - Outcomes of Carbohydrate Loading Paediatric Patients Preoperatively for Tonsillectomy and Adenoidectomy N/A
Not yet recruiting NCT03591432 - A Trial Comparing Transnasal humidified Rapid insufflation Ventilatory Exchange (THRIVE) and Apneic Oxygenation With Facemask Ventilation in Elderly Patients Undergoing Induction of Anaesthesia. N/A
Not yet recruiting NCT03275324 - Use of Integrated Pulmonary Index to Predict Post-Operative Respiratory Adverse Events in High Risk Patients N/A
Recruiting NCT02763878 - Uncut Roux-en-y Anastomosis Reduce Postoperative Complication and Improve Nutritional Status After Distal Gastrectomy Phase 3
Completed NCT02891187 - Visits Versus Telephone Calls for Postoperative Care N/A
Completed NCT02947789 - Predictive Model for Postoperative Mortality N/A
Completed NCT02766062 - Effects of Propofol and Sevoflurane on Early POCD in Elderly Patients With Metabolic Syndrome N/A
Not yet recruiting NCT02542423 - Endocan Predictive Value in Postcardiac Surgery Acute Respiratory Failure. N/A
Recruiting NCT01934049 - Postoperative Recovery in Elderly Patients Undergoing Hip Hemi-arthroplasty Phase 4
Enrolling by invitation NCT01744938 - Preoperative Biliary Drainage for the Lower Malignant Obstructive Jaundice Phase 3